Smoking cessation counseling and pneumococcal vaccine administration to parents of infants admitted to neonatal intensive care unit: A life-changing opportunity
Affiliations: Brady Russell Laboratory, Division of Neonatology, Department of Pediatrics, State University of New York at Stony Brook, Stony Brook, NY, USA
Note: [] Address for correspondence: Shetal Shah, Brady Russell Laboratory, Division of Neonatology, Department of Pediatrics, State, University of New York at Stony Brook, Health Science Center Tower 11-060, Stony Brook, NY 11794-0001, USA. Tel.: +1 631 444 7653; Fax: +1 631 444 9142; E-mail: [email protected]
Abstract: Second-hand smoke exposure is a significant health risk to newborn infants, particularly preterm infants with underlying respiratory disorders. Smoking cessation counseling during all phases of pregnancy and 23-valent pneumococcal polysaccharide vaccine (PPSV23) administration to adult smokers is advocated by multiple healthcare organizations but faces barriers to implementation. The neonatal intensive care unit is an ideal arena for providing smoking cessation counseling to parents because advice from pediatric caregivers is well received. High parental immunization rates for PPSV23 may also be achieved with NICU-bedside vaccination.
Keywords: Smoking cessation, pneumonia immunization, neonatal care
